IP Verse

Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof

PatentPatent Analysis

EP3590949

MODERNATX
Application Number
EP19177059A
Filing Date
Oct 3, 2011
Status
Granted And Under Opposition
Apr 15, 2022
Grant Date
May 18, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3394030B2
EP3853305B1
EP3431485B2

Biblio Summary

The patent EP3590949B1 was granted to Modernatx on May 18, 2022 following the initial filing on Oct 3, 2011 under the application number EP19177059A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ETHERNA IMMUNOTHERAPIESFeb 20, 2023ADMISSIBLE
MAIWALDFeb 20, 2023ADMISSIBLE
GLAXOSMITHKLINE BIOLOGICALSFeb 17, 2023ADMISSIBLE
PFIZERFeb 17, 2023ADMISSIBLE
WITHERS & ROGERSFeb 17, 2023ADMISSIBLE
KILBURN & STRODEFeb 17, 2023WITHDRAWN
SANOFIOct 5, 2022ADMISSIBLE
PATENT BOUTIQUESep 27, 2022ADMISSIBLE
BIONTECHSep 23, 2022ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents